From the Journals

Diabetes plus frequent sleep disturbances tied to higher mortality


 

FROM THE JOURNAL OF SLEEP RESEARCH

Sleep disturbances ‘highly prevalent’ among U.K. adults.

The UK Biobank enrolled just over 500,000 people aged 37-73 years during 2006-2010, and 487,728 of these people had data available that allowed their inclusion in the analysis. That group averaged about 57 years of age, 54% were women, 94% were White, and their average body mass index was 27-28 kg/m2.

More than a quarter of these people reported having “usual” sleep disturbances, showing that sleep disturbances are “highly prevalent” among U.K. residents, noted the authors. Just under a quarter of the subjects reported they never or rarely had sleep disturbances, and the remaining half of subjects said they “sometimes” had sleep disturbances.

In addition, 69% reported neither diabetes nor frequent sleep disturbances, 26% had frequent sleep disturbances but no diabetes, 3% had diabetes but not frequent sleep disturbances, and 2% had both diabetes and frequent sleep disturbances.

During the average 8.9-year follow-up, 19,177 people died from any cause (4%), and 3,874 of these deaths involved cardiovascular disease causes. Despite the significant association of diabetes and frequent sleep disturbances with an increased rate of all-cause mortality, the same combination showed no significant link with cardiovascular mortality in the study’s full-adjusted model. This may be because “frequent sleep disturbances can lead to a variety of causes of death,” Dr. Knutson suggested.

The information collected by the UK Biobank did not allow the researchers to distinguish between type 1 and type 2 diabetes.

The findings “suggest that regardless of the cause of sleep disturbance, reporting sleep disturbances on a frequent basis is an important signal of elevated risk of mortality. Such symptoms should therefore be investigated further by physicians, particularly in patients who have also been diagnosed with diabetes,” wrote Dr. Knutson and coauthors. “This is the first study to examine the effect of the combination of insomnia and diabetes on mortality risk.”

But Dr. Knutson highlighted that “sleep problems are important for everyone, not just people with diabetes.

Neither Dr. Knutson and coauthors nor Dr. Reutrakul had no disclosures.

Pages

Recommended Reading

Semaglutide boosts weight loss following endoscopic gastroplasty
Clinician Reviews
‘Twincretin’ meets primary endpoints in five pivotal diabetes trials
Clinician Reviews
Eat two fruits a day, ward off diabetes?
Clinician Reviews
Unmanaged diabetes, high blood glucose tied to COVID-19 severity
Clinician Reviews
‘Stunning’ twincretin beats semaglutide for A1c, weight reduction in T2D
Clinician Reviews
‘Staggering’ doubling of type 2 diabetes in children during pandemic
Clinician Reviews
SUSTAIN FORTE: Higher-dose semaglutide safely boosts glycemic control, weight loss
Clinician Reviews
Type 1 diabetes amputation rates fall in Sweden, rise in U.S.
Clinician Reviews
Intervention opens access to care for minority youths with type 1 diabetes
Clinician Reviews
Omnipod 5 ‘artificial pancreas’ shows benefit in type 1 diabetes
Clinician Reviews